Analyst consensus rating
Evolent Health Analyst Rating: Buy
Direct answer
Evolent Health's consensus rating is Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.75.
Forecast evidence checked October 17, 2026.
Get free Evolent Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.57
- Average price target
- $5.75
- High price target
- $8.00
- Low price target
- $3.00
- Low target gap
- -34.4%
- Target upside
- +25.8%
- High target gap
- +75.1%
- Target range width
- 109.4%
- Consensus rating
- Buy
- Analysts
- 12
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Evolent Health?
Evolent Health has a verified Buy consensus. The same dataset has an average price target of $5.75.
How far are Evolent Health's low and high targets from the recorded price?
The low target implies -34.4%, while the high target implies +75.1%.
How many analysts are included in Evolent Health's consensus?
The verified consensus includes 12 analysts.
How is Evolent Health's target upside or downside calculated?
The average target of $5.75 is divided by the recorded price of $4.57, then one is subtracted to produce +25.8%. This does not guarantee a future return.
When was Evolent Health's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.